(Q51033447)
Statements
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up. (English)
1 reference
1 reference
David Viola
1 reference
Rossella Elisei
1 reference
Eleonora Molinaro
1 reference
Carlotta Giani
1 reference
Laura Agate
1 reference
Agnese Biagini
1 reference
Letizia Pieruzzi
1 reference
Francesca Bianchi
1 reference
Federica Brozzi
1 reference
Claudia Ceccarelli
1 reference
Paolo Vitti
1 reference
Furio Pacini
1 reference
26 April 2013
1 reference
98
1 reference
7
1 reference
2693-2700
1 reference